A detailed history of Savant Capital, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 7,808 shares of TMO stock, worth $4.09 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,808
Previous 5,294 47.49%
Holding current value
$4.09 Million
Previous $2.93 Million 64.98%
% of portfolio
0.04%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$531.86 - $624.21 $1.34 Million - $1.57 Million
2,514 Added 47.49%
7,808 $4.83 Million
Q2 2024

Aug 05, 2024

SELL
$541.52 - $599.02 $37,364 - $41,332
-69 Reduced 1.29%
5,294 $2.93 Million
Q1 2024

May 03, 2024

SELL
$528.82 - $599.43 $1.14 Million - $1.29 Million
-2,155 Reduced 28.66%
5,363 $3.12 Million
Q4 2023

Feb 05, 2024

BUY
$431.41 - $532.94 $75,496 - $93,264
175 Added 2.38%
7,518 $3.99 Million
Q3 2023

Nov 06, 2023

SELL
$498.29 - $574.41 $377,703 - $435,402
-758 Reduced 9.36%
7,343 $3.72 Million
Q2 2023

Aug 04, 2023

BUY
$508.46 - $591.13 $440,326 - $511,918
866 Added 11.97%
8,101 $4.23 Million
Q1 2023

May 02, 2023

BUY
$535.0 - $604.82 $1.93 Million - $2.18 Million
3,608 Added 99.48%
7,235 $4.17 Million
Q4 2022

Feb 06, 2023

BUY
$484.71 - $571.37 $8,724 - $10,284
18 Added 0.5%
3,627 $2 Million
Q3 2022

Oct 28, 2022

SELL
$507.19 - $604.49 $26,881 - $32,037
-53 Reduced 1.45%
3,609 $1.83 Million
Q2 2022

Jul 22, 2022

BUY
$500.9 - $612.21 $186,835 - $228,354
373 Added 11.34%
3,662 $1.99 Million
Q1 2022

May 05, 2022

SELL
$524.0 - $644.92 $55,544 - $68,361
-106 Reduced 3.12%
3,289 $1.94 Million
Q4 2021

Feb 08, 2022

BUY
$569.0 - $667.24 $50,641 - $59,384
89 Added 2.69%
3,395 $2.27 Million
Q3 2021

Nov 12, 2021

SELL
$509.53 - $609.78 $7,133 - $8,536
-14 Reduced 0.42%
3,306 $1.89 Million
Q2 2021

Aug 04, 2021

BUY
$441.0 - $508.24 $67,032 - $77,252
152 Added 4.8%
3,320 $1.68 Million
Q1 2021

May 04, 2021

SELL
$439.85 - $518.83 $10,556 - $12,451
-24 Reduced 0.75%
3,168 $1.45 Million
Q4 2020

Feb 03, 2021

SELL
$435.06 - $527.66 $6,960 - $8,442
-16 Reduced 0.5%
3,192 $1.49 Million
Q3 2020

Nov 04, 2020

BUY
$359.77 - $441.52 $89,582 - $109,938
249 Added 8.42%
3,208 $1.42 Million
Q2 2020

Aug 11, 2020

BUY
$275.2 - $362.34 $16,236 - $21,378
59 Added 2.03%
2,959 $1.07 Million
Q1 2020

Apr 30, 2020

BUY
$255.3 - $340.05 $102,375 - $136,360
401 Added 16.05%
2,900 $822,000
Q4 2019

Jan 31, 2020

BUY
$271.93 - $328.04 $14,956 - $18,042
55 Added 2.25%
2,499 $812,000
Q3 2019

Nov 12, 2019

BUY
$268.46 - $305.43 $34,631 - $39,400
129 Added 5.57%
2,444 $712,000
Q2 2019

Aug 06, 2019

SELL
$257.51 - $295.55 $41,201 - $47,288
-160 Reduced 6.46%
2,315 $680,000
Q1 2019

May 02, 2019

SELL
$212.17 - $273.72 $62,590 - $80,747
-295 Reduced 10.65%
2,475 $677,000
Q4 2018

Feb 05, 2019

SELL
$208.47 - $251.98 $4,377 - $5,291
-21 Reduced 0.75%
2,770 $620,000
Q3 2018

Oct 23, 2018

BUY
$205.57 - $244.32 $1,850 - $2,198
9 Added 0.32%
2,791 $681,000
Q1 2018

Apr 27, 2018

SELL
$192.98 - $224.11 $16,403 - $19,049
-85 Reduced 2.96%
2,782 $574,000
Q4 2017

Jan 31, 2018

BUY
$182.03 - $200.37 $9,829 - $10,819
54 Added 1.92%
2,867 $544,000
Q3 2017

Oct 31, 2017

BUY
$171.74 - $194.04 $483,104 - $545,834
2,813
2,813 $532,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.